The safety, tolerability, pharmacokinetics and pharmacodynamics of FBS0701, an iron chelator in development, in phase I studies of healthy volunteers and patients with transfusional iron overload

Authors
Category Primary study
JournalHaematologica
Year 2013
This article has no abstract
Epistemonikos ID: 9de6d584aaf8e7569d999799bdab0eb33a3b6369
First added on: Feb 06, 2025